Refine
Has Fulltext
- yes (117)
Is part of the Bibliography
- yes (117)
Year of publication
Document Type
- Journal article (117) (remove)
Keywords
- metabolism (8)
- SARS-CoV-2 (5)
- apoptosis (5)
- cytokinins (5)
- COVID-19 (4)
- regulation (4)
- transcriptome (4)
- Candida albicans (3)
- bioinformatics (3)
- cisplatin (3)
- database (3)
- expression (3)
- identification (3)
- leukemic cells (3)
- molecular docking (3)
- mutation (3)
- systems biology (3)
- virulence (3)
- "-omics" (2)
- Aspergillus fumigatus (2)
- Bioinformatik (2)
- Biology (2)
- Caenorhabditis elegans (2)
- DNA (2)
- DNA storage (2)
- Metabolic pathways (2)
- RNA (2)
- Salmonella-containing vacuole (SCV) (2)
- adaptation (2)
- algorithm (2)
- alignment (2)
- annotation (2)
- cellular signalling networks (2)
- cytotoxicity (2)
- dendritic cells (2)
- differentiation (2)
- drug repurposing (2)
- engineering (2)
- evolution (2)
- infection (2)
- lung cancer (2)
- machine learning (2)
- metabolic modeling (2)
- molecular dynamics (2)
- mouse (2)
- oncolytic virus (2)
- oxidative stress (2)
- platelet (2)
- positive selection (2)
- recombination (2)
- resistance (2)
- synthetic biology (2)
- transcriptional regulation (2)
- 3D lung tumor tissue models (1)
- 3D tissue models (1)
- 6-benzylaminopurine (1)
- A2a-R receptor (1)
- ACKR4 (1)
- AIModules (1)
- AKT (1)
- Abstandsmessung (1)
- Aspergillus (1)
- Aspergillus fumigalus (1)
- Axl tyrosine kinase (1)
- B-cell (1)
- BRAF mutation (1)
- Berberine (1)
- Biologie (1)
- Boolean function (1)
- Boolean tree (1)
- C-60 fullerene (1)
- C60 fullerene (1)
- CD95 (1)
- CETCH cycle (1)
- CLAVATA3 (1)
- CLV3p (1)
- CO2-sequestration (1)
- C\(_{60}\) fullerene (1)
- Camponotus floridanus (1)
- Cell surface proteomics (1)
- Cestode (1)
- Chagas diagnosis (1)
- Chagas disease (1)
- Chagas monitoring (1)
- Chagas real time PCR (1)
- Chlamydia trachomatis (1)
- Computer modelling (1)
- Computer software (1)
- Cushing’s disease (1)
- DLS and AFM measurements (1)
- DNA damage (1)
- Doxorubicin (1)
- EMT (1)
- ERK signaling (1)
- Echinococcosis (1)
- Echinococcus (1)
- Einfluss (1)
- Embryonic induction (1)
- Enterobacteriaceae (1)
- Enzyme kinetics (1)
- Enzyme metabolism (1)
- Enzyme regulation (1)
- Enzymes (1)
- Epicardium-derived cells (1)
- Evaluation (1)
- FLS2 receptor (1)
- Functional modules (1)
- GPVI (1)
- Gene expression vectors (1)
- H7N9 influenza virus (1)
- HGPS (1)
- HIV (1)
- HeLa cells (1)
- Host-parasite interaction (1)
- Human atrial stromal cells (1)
- ICEP (1)
- ICP27 (1)
- IGFBP2 (1)
- Insulin (1)
- Integrated network analysis (1)
- IronChip Evaluation Package (1)
- KRAS biomarker signatures (1)
- Ki67 (1)
- Kinase inhibitor (1)
- Klimaneutralität (1)
- Klimapflanzen (1)
- Klimawandel (1)
- LS-MIDA (1)
- MHC I (1)
- MHC II (1)
- MITE (1)
- Metabolic profiles (1)
- Microarray (1)
- Mikroarray (1)
- Milnesium tardigradum (1)
- Mycoplasma (1)
- Neuromuscular junctions (1)
- Olea (1)
- Phylogenie (1)
- PknB (1)
- Polymerase chain reaction (1)
- Predictive toxicology (1)
- Prognose (1)
- Proteasen (1)
- Proteine (1)
- R0 (1)
- RNA secondary structure (1)
- RNA sequencing (1)
- RNA-SEQ (1)
- RNAi (1)
- Receptor kinase (1)
- Salmonella enterica (1)
- Salmonella-containing vacuole (1)
- Sanger sequencing (1)
- Septins (1)
- Shotgun method (1)
- Spumaviren (1)
- Staphylococcus aureus (1)
- Stp (1)
- Strukturanalyse (1)
- Synapses (1)
- Synaptic vesicles (1)
- Synthetic biology (1)
- T-cell (1)
- T-cell epitope (1)
- Tapeworm (1)
- Toxicity (1)
- Transcriptional control (1)
- Trend test (1)
- Trypanosoma (1)
- Trypanosoma cruzi (1)
- UV–Vis (1)
- V1–V9 (1)
- V4 (1)
- V7/V8 (1)
- VASP (1)
- Vasodilatator-stimuliertes Phosphoprotein (1)
- Vesicles (1)
- Virtual sequencing (1)
- WNT (1)
- Yolk protein (1)
- Zebrafish (1)
- Zika virus (1)
- abscisic acid (ABA) (1)
- accumulation (1)
- adaption (1)
- agent-based model (1)
- aging (1)
- alveolar fibrosis (1)
- alveolar regeneration (1)
- alzheimer's disease (1)
- alzheimers disease (1)
- animals (1)
- anti-cancer drug-like molecules (1)
- anti-thrombotic therapies (1)
- anticancer activity (1)
- antimicrobial peptides (1)
- antimycotics (1)
- antioxidants (1)
- antiproliferative (1)
- approved drugs (1)
- arabidopsis thaliana (1)
- arabidpsis thaliana (1)
- auxin (1)
- bacterial invasion (1)
- bacterial pathogens (1)
- bacteriology (1)
- beta-lactamase inhibition (1)
- binary decision diagram (1)
- binding pocket (1)
- binding protein (1)
- biofilm formation (1)
- biofuel (1)
- bioinformatics and computational biology (1)
- biological activities (1)
- biomanufacturing (1)
- biomarker (1)
- biomaterial surfaces (1)
- bioreactor culture (1)
- blood platelets (1)
- boolean in silico models (1)
- boolean modeling (1)
- brain (1)
- caenorhabditis elegans (1)
- calcium (1)
- calcium signaling pathway (1)
- camponotus floridanus (1)
- cancer therapy (1)
- candida genome database (1)
- carboxylation (1)
- carpenter ant (1)
- cascade (1)
- caspase-3 (1)
- cell death (1)
- cell staining (1)
- cell wall (1)
- centrality (1)
- cerebral ischemia (1)
- chemical similarity (1)
- chondrosarcoma (1)
- cluster (1)
- collagen (1)
- colony-stimulating factor (1)
- colorectal cancer (1)
- combinatorial drug predictions (1)
- comparative sequence analysis (1)
- complex networks (1)
- computational (1)
- computational biology and bioinformatics (1)
- computational modelling (1)
- computational prediction (1)
- computational systems biology (1)
- computer modelling (1)
- computer-assisted (1)
- connector (1)
- control group (1)
- control profiles (1)
- controllability (1)
- corticotropin-releasing hormone (1)
- crosstalk (1)
- cryptic (1)
- culture (1)
- cycle (1)
- cyclic nucleotide signaling (1)
- cytokinin (1)
- cytokinin kinetin (1)
- data mining/methods (1)
- data storage (1)
- defense and evasion strategies (1)
- defense signaling (1)
- defenses (1)
- design (1)
- deubiquitinases (1)
- differentially expressed genes (1)
- discovery (1)
- disease (1)
- docking (1)
- domain (1)
- doxorubicin (1)
- drosophila (1)
- drug design (1)
- drug release (1)
- drug resistance (1)
- drug-minded protein (1)
- dynamic protein-protein interactions (1)
- early diagnosis (1)
- efficient intervention points (1)
- elementary body (1)
- elementary modes (1)
- encapsulation (1)
- encephalitis dementia (1)
- enteric pathogens (1)
- enterica serovar Typhimurium (1)
- enzyme (1)
- epitope mapping (1)
- epitope prediction (1)
- error (1)
- error-transfer (1)
- eugenol (1)
- evolutionary (1)
- exome (1)
- explainability of machine learning (1)
- expressed sequence tag (1)
- facultatively intracellular pathogens (1)
- feature analysis (1)
- feature selection (1)
- flg22 (1)
- fluorescence recovery after photobleaching (1)
- flux balance analysis (1)
- format (1)
- fostamatinib (1)
- free energy (1)
- functional modules (1)
- fungal pathogens (1)
- fungicide (1)
- gamma (1)
- gene expression (1)
- gene ontology (1)
- genes (1)
- genetic regulatory network (1)
- genetic variation (1)
- genetics (1)
- genome browser (1)
- genus Aspergillus (1)
- guard cells (1)
- hepatotoxicity (1)
- histidine kinase (1)
- homology modeling (1)
- host-pathogen adaption (1)
- host-pathogen interaction (1)
- human (1)
- human immune system (1)
- human immunodeficiency virus (1)
- human pathogenic fungi (1)
- human xenografted mouse models (1)
- humans (1)
- image processing (1)
- imaging (1)
- immune system (1)
- immune-informatics (1)
- immunity (1)
- immunological cross-talk (1)
- immunotherapies (1)
- in silico simulation (1)
- in vitro (1)
- in vivo toxicity (1)
- in-vitro (1)
- infected-cell protein (1)
- infection biology (1)
- infection spread (1)
- inhibitor (1)
- interaction (1)
- interaction map (1)
- interaction networks (1)
- interactome (1)
- intermediate host (1)
- internal transcribed spacer 2 (1)
- interolog (1)
- interpolation (1)
- interspecies comparison (1)
- invasion (1)
- invasiveness (1)
- ion signaling (1)
- isotopolog profiling (1)
- kinase signaling (1)
- kinetin (1)
- lactate dehydrogenase (1)
- lethality rate (1)
- life-span regulation (1)
- light-gated proteins (1)
- lncRNAs (1)
- lymphocytes (1)
- lymphotoxicity (1)
- mammalian system (1)
- messenger RNA (1)
- meta-data (1)
- meta-transcriptome (1)
- metabolic flux (1)
- metabolic modelling (1)
- metabolic pathways (1)
- metabolomic profiling (1)
- miRNAs (1)
- microRNAs (1)
- microRNA–target interaction (1)
- microarray (1)
- microbes (1)
- model reduction (1)
- modeling (1)
- models (1)
- modular tumor tissue models (1)
- modulatory effects (1)
- molecular cloning (1)
- molecular dynamics simulation (1)
- molecular evolution (1)
- molecular modeling (1)
- molecular systematics (1)
- mortality (1)
- mosquito (1)
- mouse model (1)
- nanocarrier (1)
- nanocellulose (1)
- nanocomplex (1)
- natural language processing (1)
- natural processing (1)
- neisseria meningitidis (1)
- network (1)
- network analysis (1)
- network biology (1)
- network inference (1)
- network simulation (1)
- neuraminidase (1)
- next generation sequencing (1)
- nitric oxide (1)
- non-invasive biomarkers (1)
- noncovalent complex (1)
- noncovalent nanocomplex (1)
- nucleic acid motifs (1)
- olive (1)
- omics (1)
- optimal drug combination (1)
- optimal drug targeting (1)
- optimal pharmacological modulation (1)
- optimal treatment strategies (1)
- optogenetics (1)
- organogenesis (1)
- origin (1)
- pH (1)
- pangolin (1)
- parasite (1)
- pathogen-host interaction (PHI) (1)
- pathogenesis (1)
- pathogenicity (1)
- pathways (1)
- patient data (1)
- pharmacology (1)
- phosphoproteome (1)
- phosphorylation (1)
- photodynamic chemotherapy (1)
- photorespiration (1)
- phylogenetic analysis (1)
- phylogenetic tree (1)
- phylogenetics (1)
- phylogeny (1)
- phytohormones (1)
- plant hormones (1)
- plant system (1)
- pollen tube (1)
- population coverage (1)
- potential role (1)
- principal (1)
- pro-oxidant (1)
- progeria (1)
- promoter (1)
- protease; Indinavir; lead expansion; docking; pharmacophore (1)
- protein (1)
- protein analysis (1)
- protein chip (1)
- protein familiy (1)
- protein interaction database (1)
- protein-protein interaction (1)
- protein-protein interaction network (1)
- proteins (1)
- proteome (1)
- pseudomas-syringae (1)
- pyrazolo[3,4-d]pyrimidine (1)
- radiation (1)
- rational drug design (1)
- re-annotation (1)
- receptor (1)
- regulatory networks (1)
- relA (1)
- reliability (1)
- reproductive toxicity (1)
- response regulator (1)
- reticulate body (1)
- ribosomal RNA (1)
- riboswitch (1)
- richtersius coronifer (1)
- scaffold search (1)
- secondary structure (1)
- sensor (1)
- sequence (1)
- sequence alignment (1)
- shoot apical meristem (1)
- signaling (1)
- signaling network (1)
- signaling pathway (1)
- signalling (1)
- signalling pathways (1)
- silico model (1)
- simulation (1)
- single cell analysis (1)
- single-electron transistors (1)
- sky kinases (1)
- software (1)
- somatic mutations (1)
- spanlastic (1)
- splicing factors (1)
- stable state (1)
- stable-isotope (1)
- stem cell niche (1)
- stem-cell-triggered immunity (1)
- stemness (1)
- stratification (1)
- stringent response (1)
- structure (1)
- structure-activity relationship (1)
- sun exposure (1)
- superoxide-dismutase (1)
- synaptic vesicles (1)
- synergistic effect (1)
- synthetic pathways (1)
- system inference (1)
- tardigrada (1)
- target (1)
- targeted combination therapy (1)
- targeted therapy (1)
- targets (1)
- therapeutic strategy (1)
- thrombosis (1)
- tolerance (1)
- tools overview (1)
- transcription (1)
- translation (1)
- transmission (1)
- tumors (1)
- type 1 (1)
- uptake (1)
- variable regions (1)
- variants (1)
- virulenceregulatory evolution (1)
- viruses (1)
- vitellogenin (1)
- water stress (1)
- wrong labelling (1)
- xanthurenic acid (1)
- yvcK/glmR operon (1)
Institute
- Theodor-Boveri-Institut für Biowissenschaften (117) (remove)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 031A408B (1)
- CoG 721016–HERPES (1)
- ESF-ZDEX 4.0 (1)
The rapid development of green and sustainable materials opens up new possibilities in the field of applied research. Such materials include nanocellulose composites that can integrate many components into composites and provide a good chassis for smart devices. In our study, we evaluate four approaches for turning a nanocellulose composite into an information storage or processing device: 1) nanocellulose can be a suitable carrier material and protect information stored in DNA. 2) Nucleotide-processing enzymes (polymerase and exonuclease) can be controlled by light after fusing them with light-gating domains; nucleotide substrate specificity can be changed by mutation or pH change (read-in and read-out of the information). 3) Semiconductors and electronic capabilities can be achieved: we show that nanocellulose is rendered electronic by iodine treatment replacing silicon including microstructures. Nanocellulose semiconductor properties are measured, and the resulting potential including single-electron transistors (SET) and their properties are modeled. Electric current can also be transported by DNA through G-quadruplex DNA molecules; these as well as classical silicon semiconductors can easily be integrated into the nanocellulose composite. 4) To elaborate upon miniaturization and integration for a smart nanocellulose chip device, we demonstrate pH-sensitive dyes in nanocellulose, nanopore creation, and kinase micropatterning on bacterial membranes as well as digital PCR micro-wells. Future application potential includes nano-3D printing and fast molecular processors (e.g., SETs) integrated with DNA storage and conventional electronics. This would also lead to environment-friendly nanocellulose chips for information processing as well as smart nanocellulose composites for biomedical applications and nano-factories.
For SARS-CoV-2, R0 calculations in the range of 2–3 dominate the literature, but much higher estimates have also been published. Because capacity for RT-PCR testing increased greatly in the early phase of the Covid-19 pandemic, R0 determinations based on these incidence values are subject to strong bias. We propose to use Covid-19-induced excess mortality to determine R0 regardless of RT-PCR testing capacity. We used data from the Robert Koch Institute (RKI) on the incidence of Covid cases, Covid-related deaths, number of RT-PCR tests performed, and excess mortality calculated from data from the Federal Statistical Office in Germany. We determined R0 using exponential growth estimates with a serial interval of 4.7 days. We used only datasets that were not yet under the influence of policy measures (e.g., lockdowns or school closures). The uncorrected R0 value for the spread of SARS-CoV-2 based on RT-PCR incidence data was 2.56 (95% CI 2.52–2.60) for Covid-19 cases and 2.03 (95% CI 1.96–2.10) for Covid-19-related deaths. However, because the number of RT-PCR tests increased by a growth factor of 1.381 during the same period, these R0 values must be corrected accordingly (R0corrected = R0uncorrected/1.381), yielding 1.86 for Covid-19 cases and 1.47 for Covid-19 deaths. The R0 value based on excess deaths was calculated to be 1.34 (95% CI 1.32–1.37). A sine-function-based adjustment for seasonal effects of 40% corresponds to a maximum value of R0January = 1.68 and a minimum value of R0July = 1.01. Our calculations show an R0 that is much lower than previously thought. This relatively low range of R0 fits very well with the observed seasonal pattern of infection across Europe in 2020 and 2021, including the emergence of more contagious escape variants such as delta or omicron. In general, our study shows that excess mortality can be used as a reliable surrogate to determine the R0 in pandemic situations.
Nucleic acid motifs consist of conserved and variable nucleotide regions. For functional action, several motifs are combined to modules. The tool AIModules allows identification of such motifs including combinations of them and conservation in several nucleic acid stretches. AIModules recognizes conserved motifs and combinations of motifs (modules) allowing a number of interesting biological applications such as analysis of promoter and transcription factor binding sites (TFBS), identification of conserved modules shared between several gene families, e.g. promoter regions, but also analysis of shared and conserved other DNA motifs such as enhancers and silencers, in mRNA (motifs or regulatory elements e.g. for polyadenylation) and lncRNAs. The tool AIModules presented here is an integrated solution for motif analysis, offered as a Web service as well as downloadable software. Several nucleotide sequences are queried for TFBSs using predefined matrices from the JASPAR DB or by using one’s own matrices for diverse types of DNA or RNA motif discovery. Furthermore, AIModules can find TFBSs common to two or more sequences. Demanding high or low conservation, AIModules outperforms other solutions in speed and finds more modules (specific combinations of TFBS) than alternative available software. The application also searches RNA motifs such as polyadenylation site or RNA–protein binding motifs as well as DNA motifs such as enhancers as well as user-specified motif combinations (https://bioinfo-wuerz.de/aimodules/; alternative entry pages: https://aimodules.heinzelab.de or https://www.biozentrum.uni-wuerzburg.de/bioinfo/computing/aimodules). The application is free and open source whether used online, on-site, or locally.
Epithelial-to-mesenchymal transition (EMT) is discussed to be centrally involved in invasion, stemness, and drug resistance. Experimental models to evaluate this process in its biological complexity are limited. To shed light on EMT impact and test drug response more reliably, we use a lung tumor test system based on a decellularized intestinal matrix showing more in vivo-like proliferation levels and enhanced expression of clinical markers and carcinogenesis-related genes. In our models, we found evidence for a correlation of EMT with drug resistance in primary and secondary resistant cells harboring KRAS\(^{G12C}\) or EGFR mutations, which was simulated in silico based on an optimized signaling network topology. Notably, drug resistance did not correlate with EMT status in KRAS-mutated patient-derived xenograft (PDX) cell lines, and drug efficacy was not affected by EMT induction via TGF-β. To investigate further determinants of drug response, we tested several drugs in combination with a KRAS\(^{G12C}\) inhibitor in KRAS\(^{G12C}\) mutant HCC44 models, which, besides EMT, display mutations in P53, LKB1, KEAP1, and high c-MYC expression. We identified an aurora-kinase A (AURKA) inhibitor as the most promising candidate. In our network, AURKA is a centrally linked hub to EMT, proliferation, apoptosis, LKB1, and c-MYC. This exemplifies our systemic analysis approach for clinical translation of biomarker signatures.
Conventional anticancer chemotherapy is limited because of severe side effects as well as a quickly evolving multidrug resistance of the tumor cells. To address this problem, we have explored a C\(_{60}\) fullerene-based nanosized system as a carrier for anticancer drugs for an optimized drug delivery to leukemic cells.Here, we studied the physicochemical properties and anticancer activity of C\(_{60}\) fullerene noncovalent complexes with the commonly used anticancer drug doxorubicin. C\(_{60}\)-Doxorubicin complexes in a ratio 1:1 and 2:1 were characterized with UV/Vis spectrometry, dynamic light scattering, and high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The obtained analytical data indicated that the 140-nm complexes were stable and could be used for biological applications. In leukemic cell lines (CCRF-CEM, Jurkat, THP1 and Molt-16), the nanocomplexes revealed 3.5 higher cytotoxic potential in comparison with the free drug in a range of nanomolar concentrations. Also, the intracellular drug's level evidenced C\(_{60}\) fullerene considerable nanocarrier function.The results of this study indicated that C\(_{60}\) fullerene-based delivery nanocomplexes had a potential value for optimization of doxorubicin efficiency against leukemic cells.
The olive tree is a venerable Mediterranean plant and often used in traditional medicine. The main aim of the present study was to evaluate the effect of Olea europaea L. cv. Arbosana leaf extract (OLE) and its encapsulation within a spanlastic dosage form on the improvement of its pro-oxidant and antiproliferative activity against HepG-2, MCF-7, and Caco-2 human cancer cell lines. The LC-HRESIMS-assisted metabolomic profile of OLE putatively annotated 20 major metabolites and showed considerable in vitro antiproliferative activity against HepG-2, MCF-7, and Caco-2 cell lines with IC\(_{50}\) values of 9.2 ± 0.8, 7.1 ± 0.9, and 6.5 ± 0.7 µg/mL, respectively. The encapsulation of OLE within a (spanlastic) nanocarrier system, using a spraying method and Span 40 and Tween 80 (4:1 molar ratio), was successfully carried out (size 41 ± 2.4 nm, zeta potential 13.6 ± 2.5, and EE 61.43 ± 2.03%). OLE showed enhanced thermal stability, and an improved in vitro antiproliferative effect against HepG-2, MCF-7, and Caco-2 (IC\(_{50}\) 3.6 ± 0.2, 2.3 ± 0.1, and 1.8 ± 0.1 µg/mL, respectively) in comparison to the unprocessed extract. Both preparations were found to exhibit pro-oxidant potential inside the cancer cells, through the potential inhibitory activity of OLE against glutathione reductase and superoxide dismutase (IC\(_{50}\) 1.18 ± 0.12 and 2.33 ± 0.19 µg/mL, respectively). These inhibitory activities were proposed via a comprehensive in silico study to be linked to the presence of certain compounds in OLE. Consequently, we assume that formulating such a herbal extract within a suitable nanocarrier would be a promising improvement of its therapeutic potential.
Climate plants are critical to prevent global warming as all efforts to save carbon dioxide are too slow and climate disasters on the rise. For best carbon dioxide harvesting we compare algae, trees and crop plants and use metagenomic analysis of environmental samples. We compare different pathways, carbon harvesting potentials of different plants as well as synthetic modifications including carbon dioxide flux balance analysis. For implementation, agriculture and modern forestry are important.
Background: Chagas disease (CD) is a major burden in Latin America, expanding also to non-endemic countries. A gold standard to detect the CD causing pathogen Trypanosoma cruzi is currently not available. Existing real time polymerase chain reactions (RT-PCRs) lack sensitivity and/or specificity. We present a new, highly specific RT-PCR for the diagnosis and monitoring of CD. Material and Methods: We analyzed 352 serum samples from Indigenous people living in high endemic CD areas of Colombia using three leading RT-PCRs (k-DNA-, TCZ-, 18S rRNA-PCR), the newly developed one (NDO-PCR), a Rapid Test/enzyme-linked immuno sorbent assay (ELISA), and immunofluorescence. Eighty-seven PCR-products were verified by sequence analysis after plasmid vector preparation. Results: The NDO-PCR showed the highest sensitivity (92.3%), specificity (100%), and accuracy (94.3%) for T. cruzi detection in the 87 sequenced samples. Sensitivities and specificities of the kDNA-PCR were 89.2%/22.7%, 20.5%/100% for TCZ-PCR, and 1.5%/100% for the 18S rRNA-PCR. The kDNA-PCR revealed a 77.3% false positive rate, mostly due to cross-reactions with T. rangeli (NDO-PCR 0%). TCZ- and 18S rRNA-PCR showed a false negative rate of 79.5% and 98.5% (NDO-PCR 7.7%), respectively. Conclusions: The NDO-PCR demonstrated the highest specificity, sensitivity, and accuracy compared to leading PCRs. Together with serologic tests, it can be considered as a reliable tool for CD detection and can improve CD management significantly.
Synergy of chemo- and photodynamic therapies with C\(_{60}\) Fullerene-Doxorubicin nanocomplex
(2019)
A nanosized drug complex was explored to improve the efficiency of cancer chemotherapy, complementing it with nanodelivery and photodynamic therapy. For this, nanomolar amounts of a non-covalent nanocomplex of Doxorubicin (Dox) with carbon nanoparticle C\(_{60}\) fullerene (C\(_{60}\)) were applied in 1:1 and 2:1 molar ratio, exploiting C\(_{60}\) both as a drug-carrier and as a photosensitizer. The fluorescence microscopy analysis of human leukemic CCRF-CEM cells, in vitro cancer model, treated with nanocomplexes showed Dox’s nuclear and C\(_{60}\)'s extranuclear localization. It gave an opportunity to realize a double hit strategy against cancer cells based on Dox's antiproliferative activity and C\(_{60}\)'s photoinduced pro-oxidant activity. When cells were treated with 2:1 C\(_{60}\)-Dox and irradiated at 405 nm the high cytotoxicity of photo-irradiated C\(_{60}\)-Dox enabled a nanomolar concentration of Dox and C\(_{60}\) to efficiently kill cancer cells in vitro. The high pro-oxidant and pro-apoptotic efficiency decreased IC\(_{50}\) 16, 9 and 7 × 10\(^3\)-fold, if compared with the action of Dox, non-irradiated nanocomplex, and C\(_{60}\)'s photodynamic effect, correspondingly. Hereafter, a strong synergy of therapy arising from the combination of C\(_{60}\)-mediated Dox delivery and C\(_{60}\) photoexcitation was revealed. Our data indicate that a combination of chemo- and photodynamic therapies with C\(_{60}\)-Dox nanoformulation provides a promising synergetic approach for cancer treatment.
Circadian endogenous clocks of eukaryotic organisms are an established and rapidly developing research field. To investigate and simulate in an effective model the effect of external stimuli on such clocks and their components we developed a software framework for download and simulation. The application is useful to understand the different involved effects in a mathematical simple and effective model. This concerns the effects of Zeitgebers, feedback loops and further modifying components. We start from a known mathematical oscillator model, which is based on experimental molecular findings. This is extended with an effective framework that includes the impact of external stimuli on the circadian oscillations including high dose pharmacological treatment. In particular, the external stimuli framework defines a systematic procedure by input-output-interfaces to couple different oscillators. The framework is validated by providing phase response curves and ranges of entrainment. Furthermore, Aschoffs rule is computationally investigated. It is shown how the external stimuli framework can be used to study biological effects like points of singularity or oscillators integrating different signals at once. The mathematical framework and formalism is generic and allows to study in general the effect of external stimuli on oscillators and other biological processes. For an easy replication of each numerical experiment presented in this work and an easy implementation of the framework the corresponding Mathematica files are fully made available. They can be downloaded at the following link: https://www.biozentrum.uni-wuerzburg.de/bioinfo/computing/circadian/.